Common side effects and guidance on treatment methods during Rasagiline medication

Rasagiline (Rasagiline) is a selective monoamine oxidase MAO-B (MAO-B) inhibitor that is commonly used in the treatment of patients with Parkinson's disease, especially in the early stages of the disease or when combined with levodopa, to help improve motor symptoms. However, although the drug is generally well tolerated, some patients may still experience some side effects during treatment, which requires close attention and timely response.

One of the common side effects is central nervous system symptoms such as headache, dizziness, and fatigue. This type of discomfort usually occurs during drug initiation or dose adjustment, and is generally a mild and temporary reaction. If the symptoms are mild, the patient is advised to rest and avoid strenuous activities; if it affects daily life, the patient should report it to the doctor to evaluate whether the medication regimen needs to be adjusted or symptomatic treatment needs to be provided.

Another more common problem is gastrointestinal discomfort, including nausea, dry mouth, indigestion, or constipation. These side effects often occur in the early stages of medication and usually resolve gradually as medication continues. It is recommended that patients take the medicine with a small amount of food to help reduce gastric irritation; at the same time, maintaining adequate water and moderate exercise can help improve constipation. If symptoms worsen significantly, seek medical attention promptly.

A small number of patients may develop motor complications, such as dyskinesias or hypotension, especially orthostatic hypotension, when combined with levodopa. At this time, changes in blood pressure should be monitored, especially when getting up in the morning or after sitting for a long time, and avoid getting up suddenly. Doctors may consider adjusting the dose of rasagiline or levodopa if necessary. In addition, it is necessary to avoid combining it with cold medicines containing ingredients such as dextromethorphan and ephedrine to avoid causing hypertensive crisis. Overall, rational medication use and timely management can greatly reduce the risk of adverse reactions to rasagiline.

Reference materials:https://www.azilect.com/